{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:16Z","timestamp":1786980136225,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T00:00:00Z","timestamp":1253145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00415-009-5318-9","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T11:52:10Z","timestamp":1253101930000},"page":"338-343","source":"Crossref","is-referenced-by-count":11,"title":["Unsatisfactory outcomes in myasthenia gravis: influence by care providers"],"prefix":"10.1007","volume":"257","author":[{"given":"Murielle","family":"Dunand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan A.","family":"Botez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Borruat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Roux-Lombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Spertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Kuntzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,17]]},"reference":[{"key":"5318_CR1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/mus.1140","volume":"24","author":"AAEM Quality Assurance Committee","year":"2001","unstructured":"AAEM Quality Assurance Committee (2001) Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert\u2013Eaton myasthenic syndrome. Muscle Nerve 24:1239\u20131247","journal-title":"Muscle Nerve"},{"key":"5318_CR2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s001150050354","volume":"69","author":"H Glucker","year":"1998","unstructured":"Glucker H, Nix WA, Willenberg H, Hoffmann SO (1998) Zur Krankheitsverarbeitung bei Myasthenia gravis im Vergleich mit anderen chronischen neuromuskularer Erkrankungen. Nervenarzt 69:858\u2013863","journal-title":"Nervenarzt"},{"key":"5318_CR3","doi-asserted-by":"crossref","unstructured":"Hart IK, Sathasivam S, Sharshar T (2007) Immunosuppressive agents for myasthenia gravis. Cochrane Database Syst Rev CD005224","DOI":"10.1002\/14651858.CD005224.pub2"},{"key":"5318_CR4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jnnp.2007.118950","volume":"79","author":"M Hill","year":"2008","unstructured":"Hill M, Ben-Shlomo Y (2008) Neurological care and risk of hospital mortality for patients with myasthenia gravis in England. J Neurol Neurosurg Psychiatry 79:421\u2013425","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5318_CR5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/WNL.38.2.258","volume":"38","author":"R Hohlfeld","year":"1988","unstructured":"Hohlfeld R, Michels M, Heininger K, Besinger U, Toyka KV (1988) Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis. Neurology 38:258\u2013261","journal-title":"Neurology"},{"key":"5318_CR6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki III","year":"2000","unstructured":"Jaretzki A III, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323","journal-title":"Neurology"},{"key":"5318_CR7","doi-asserted-by":"crossref","first-page":"II90","DOI":"10.1007\/s00415-007-2022-5","volume":"254","author":"W Kohler","year":"2007","unstructured":"Kohler W (2007) Psychosocial aspects in patients with myasthenia gravis. J Neurol 254:II90\u2013II92","journal-title":"J Neurol"},{"key":"5318_CR8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/014107680710000230","volume":"100","author":"MR Lee","year":"2007","unstructured":"Lee MR (2007) The miracle at St Alfege\u2019s: seventy years on. J R Soc Med 100:108\u2013109","journal-title":"J R Soc Med"},{"key":"5318_CR9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T (2005) Adherence to Medication. N Engl J Med 353:487\u2013497","journal-title":"N Engl J Med"},{"key":"5318_CR10","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","volume":"61","author":"DP Richman","year":"2003","unstructured":"Richman DP, Agius MA (2003) Treatment of autoimmune myasthenia gravis. Neurology 61:1652\u20131661","journal-title":"Neurology"},{"key":"5318_CR11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1468-1331.2006.01382.x","volume":"13","author":"C Rozsa","year":"2006","unstructured":"Rozsa C, Lovas G, Fornadi L, Szabo G, Komoly S (2006) Safety of long-term combined immunosuppressive treatment in myasthenia gravis\u2014analysis of adverse effects of 163 patients. Eur J Neurol 13:947\u2013952","journal-title":"Eur J Neurol"},{"key":"5318_CR12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2006.01476.x","volume":"13","author":"GO Skeie","year":"2006","unstructured":"Skeie GO, Apostolski S, Evoli A, Gilhus NE, Hart IK, Harms L, Hilton-Jones D, Melms A, Verschuuren J, Horge HW (2006) Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 13:691\u2013699","journal-title":"Eur J Neurol"},{"key":"5318_CR13","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/WNL.57.6.1118","volume":"57","author":"GA Suarez","year":"2001","unstructured":"Suarez GA, Chalk CH, Russell JW, Kim SM, O\u2019Brien PC, Dyck PJ (2001) Diagnostic accuracy and certainty from sequential evaluations in peripheral neuropathy. Neurology 57:1118\u20131120","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5318-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-009-5318-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5318-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:12:53Z","timestamp":1559056373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-009-5318-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,17]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["5318"],"URL":"https:\/\/doi.org\/10.1007\/s00415-009-5318-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,17]]}}}